EUVIMEDEUVIMED entdecken
Crossref

Amenorrhea in adolescents using the etonogestrel contraceptive implant

Danielle Tsevat, Rebecca Mercier, Camryn Bernheimer, Stephanie Lin, Beth Schwartz

Contraception · 2024

DOI: 10.1016/j.contraception.2024.110413 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contraception, 2024. Verfasst von Danielle Tsevat und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. Electronic address: danielle_ts…. Hauptthemen laut MEDLINE: Contraceptive Agents, Female. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Clinical factors related to development of amenorrhea in adolescents with the etonogestrel contraceptive implant are not well-understood. The purpose of this study is to describe what baseline clinical characteristics are associated with amenorrhea in adolescents with a contraceptive implant 12 months after placement. STUDY DESIGN: This retrospective cohort study included 252 post-menarchal individuals aged 12-22 years with a contraceptive implant placed between 2016-2020. Data abstracted at insertion, three months post-insertion, and 12 months post-insertion included demographics, baseline bleeding pattern, prior contraception use, post-insertion bleeding pattern, and method discontinuation. We assessed possible predictive characteristics of our outcomes using bivariate and multivariable logistic regression analyses. RESULTS: Twenty nine percent of patients were amenorrheic 12 months after placement. Patients who were amenorrheic at 12 months were more likely to be obese (41.1% vs 24.6%, p = 0.01), to have been amenorrheic prior to implant insertion (16.9% vs 5.4%, p < 0.01, to have used hormonal contraception immediately prior to insertion (42.5% vs 26.3%, p = 0.01), to have had the most recent contraceptive method being another implant (12.3% vs 3.6%, p = 0.02), and to have developed amenorrhea within three months after placement (22.2% vs 12.6%, p < 0.01). After multivariable regression analysis, only obesity (adjusted odds ratio [aOR] 2.2 95% CI 1.1-4.2) and amenorrhea at three months (aOR 3.6, CI 1.1-11.5) were associated with amenorrhea at 12 months. CONCLUSION: Obesity and early amenorrhea were associated with 12-month amenorrhea in adolescents using the etonogestrel subdermal implant. Understanding this can help with contraceptive method selection and counseling for patients and providers. IMPLICATIONS: Obesity and early amenorrhea with the etonogestrel contraceptive implant are associated with longer-term amenorrhea in adolescents using this method. These findings can aid providers with method selection and pre-insertion decision-making for adolescents considering contraceptive implant use, as well as continued counseling after placement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contraceptive Agents, FemaleFemaleHumansAdolescentAmenorrheaRetrospective StudiesDesogestrelObesityDrug Implants

Stichwörter der Autor:innen

AdolescentsAmenorrheaBleeding patternBothersome bleedingContraceptionYoung adults

Substanzen

etonogestrelContraceptive Agents, FemaleDesogestrelDrug Implants

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. Electronic address: danielle_tsevat@med.unc.edu.
  • Department of Obstetrics and Gynecology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, United States.
  • Department of Obstetrics and Gynecology, Jersey Shore University Medical Center, Neptune Township, New Jersey, United States.
  • Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, United States.
  • Department of Obstetrics and Gynecology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, United States; Division of Adolescent Medicine and Pediatric Gynecology, Nemours Children's Health…

Zitieren

APA

Tsevat, D., Mercier, R., Bernheimer, C., Lin, S., & Schwartz, B. (2024). Amenorrhea in adolescents using the etonogestrel contraceptive implant. Contraception. https://doi.org/10.1016/j.contraception.2024.110413

Vancouver

Tsevat D, Mercier R, Bernheimer C, Lin S, Schwartz B. Amenorrhea in adolescents using the etonogestrel contraceptive implant. Contraception. 2024. doi:10.1016/j.contraception.2024.110413

BibTeX
@article{Tsevat2024,
  author = {Tsevat, Danielle and Mercier, Rebecca and Bernheimer, Camryn and Lin, Stephanie and Schwartz, Beth},
  title = {Amenorrhea in adolescents using the etonogestrel contraceptive implant},
  journal = {Contraception},
  year = {2024},
  doi = {10.1016/j.contraception.2024.110413}
}
Kostenlos starten →